U.S. Banks Stock News

Palomar Holdings (PLMR) heads into its Q4 2025 earnings release today at 4:00 PM Eastern, shortly after securing a new US$450 million unsecured credit facility that increases its financial flexibility and funding options. See our latest analysis for Palomar Holdings. The stock has picked up near term momentum, with a 1 day share price return of 2.14% and 7 day share price return of 6.04%. The 1 year total shareholder return of 17.16% sits against a much stronger 3 year total shareholder...

Impinj FY 2025 Earnings Snapshot Sets Up a Margins Story for Investors Impinj (PI) has just wrapped up FY 2025 with Q4 revenue of US$92.8 million and a basic EPS loss of US$0.04, alongside trailing twelve month revenue of US$361.1 million and basic EPS of US$0.37 in losses. Over the past six quarters, the company has seen quarterly revenue move between US$74.3 million and US$97.9 million, while basic EPS has swung from a profit of US$0.40 in Q2 2025 to losses such as US$0.44 in Q3 2025 and...

In recent months, LandBridge Company LLC has drawn attention for highlighting that most of its revenue comes from surface use royalties tied to pore space, particularly through its relationship with WaterBridge, while recent acquisitions have expanded its pore space footprint. A key takeaway for investors is that LandBridge’s underlying value appears increasingly tied to its ownership of subsurface pore space rather than to datacenter development, positioning it as a differentiated play on...

If you are wondering whether Luckin Coffee's current price really reflects its business today, you are not alone. Many investors are asking the same question. The stock last closed at US$37.10, with returns of 6.3% over 7 days, 12.0% over 30 days, 4.8% year to date, 26.9% over 1 year and a very large gain over 5 years that is above 5x. Recent headlines around Luckin Coffee have focused on its position in China's coffee market and how the brand is competing for consumer attention. This helps...

Why expectations around Excelerate Energy’s earnings are moving the stock Recent interest in Excelerate Energy (EE) is being driven by expectations around its upcoming earnings report on February 25, 2026, following a pattern of earnings surprises in recent quarters. See our latest analysis for Excelerate Energy. That backdrop of earnings optimism is lining up with strong recent momentum, with a 30 day share price return of 28.47%, a 90 day share price return of 44.19%, and a 3 year total...

EVI Industries (EVI) has reported Q2 2026 revenue of US$115.3 million and basic EPS of US$0.16, alongside trailing 12 month revenue of US$427.1 million and EPS of US$0.49 that frame the latest quarter within a broader earnings picture. The company has seen quarterly revenue move from US$92.7 million in Q2 2025 to US$115.3 million in Q2 2026, with basic EPS over the same quarters shifting from US$0.08 to US$0.16 as trailing net profit margins eased from 1.8% to 1.5%. This sets up a results...

Jumia Technologies FY 2025 Earnings Snapshot Jumia Technologies (NYSE:JMIA) closed FY 2025 with fourth quarter revenue of US$61.4 million and a net income loss of US$10.3 million, while trailing twelve month revenue stood at US$188.9 million against a trailing loss of US$61.6 million. Over the last year, the company has seen quarterly revenue move from US$36.3 million in Q1 2025 to US$61.4 million in Q4, with trailing twelve month losses narrowing from US$99.1 million at the end of 2024 to...

In recent days, United States Antimony Corporation announced that its Chairman and CEO, Gary C. Evans, appeared on Bloomberg Television’s Businessweek Daily to discuss a new joint venture tied to the company’s expanding critical minerals operations across the U.S., Mexico, and Canada. This comes as the company has grown into a roughly US$1.08 billion producer and processor of antimony, zeolite, and other critical minerals, highlighting how business expansion can compound investor outcomes...

Xylem (XYL) closed out FY 2025 with Q4 revenue of US$2.4b and basic EPS of US$1.37, on net income of US$335m, while trailing 12 month revenue stood at US$9.0b with basic EPS of US$3.93 supported by US$957m of net income. The company has seen revenue move from US$8.6b and basic EPS of US$3.67 on net income of US$890m in the prior trailing period to the latest US$9.0b and US$3.93 on US$957m. This sets up a story where investors are likely to focus on how steady margin progression and earnings...

If you are wondering whether UnitedHealth Group is starting to look attractively priced, this article will walk through what the current share price might be implying about value. The stock last closed at US$273.22, with returns of a 3.9% decline over 7 days, a 20.6% decline over 30 days, an 18.8% decline year to date, a 47.6% decline over 1 year, a 41.4% decline over 3 years and an 8.7% decline over 5 years. Recent headlines around UnitedHealth Group have focused on the share price...

Why the ACROBAT data presentation matters for CareDx CareDx (CDNA) is back in focus after announcing that full 24 month follow up data from its ACROBAT study of the AlloHeme relapse monitoring test will be presented at the 2026 Tandem Meetings in Salt Lake City. The ACROBAT trial tracks AlloHeme, an AI powered NGS blood test aimed at detecting relapse earlier than traditional methods in patients who have undergone allogeneic hematopoietic cell transplantation for conditions such as Acute...

Datadog (DDOG) has wrapped up FY 2025 with fourth quarter revenue of US$953.2 million and basic EPS of US$0.13, alongside net income of US$46.6 million. This puts a clear spotlight on how its topline and per share earnings are tracking as the year closes out. Over the past six quarters, revenue has moved from US$690.0 million in Q3 2024 to US$953.2 million in Q4 2025. Over the same period, quarterly basic EPS has ranged from US$0.15 in Q3 2024 to US$0.01 in Q2 2025 and then to US$0.13 in the...

Friedman Industries Q3 2026 Earnings Snapshot Friedman Industries (FRD) has reported Q3 2026 results with total revenue of US$168.0 million, net income of US$3.0 million and basic EPS of US$0.43, setting the tone for another data heavy quarter for investors to assess. The company has seen quarterly revenue move from US$106.8 million in Q2 2025 to US$94.1 million in Q3 2025, then to US$129.2 million in Q4 2025, US$134.8 million in Q1 2026, US$152.4 million in Q2 2026 and US$168.0 million in Q3...

Arrowhead Pharmaceuticals (NasdaqGS:ARWR) has been added to the S&P 400 index and its related sector indices. At the same time, the company has been removed from the S&P 600 index, shifting its classification within the S&P family. This index change reflects a reclassification of Arrowhead's market standing and may affect how index funds and ETFs hold the stock. Arrowhead Pharmaceuticals focuses on RNA interference based therapies, an area that has attracted steady attention as drug...

In the past week, Fastly drew attention ahead of its latest earnings release, with analysts reiterating forecasts after the company previously reported US$158.2 million in quarterly revenue, up 15.3% year on year and above expectations. Recent analyst commentary has highlighted steady estimates, a generally cautious but positive tone on traffic growth and pricing, and Fastly’s record of usually meeting or beating revenue forecasts as key reasons investors are closely watching the upcoming...

Goodyear Tire & Rubber (GT) has wrapped up FY 2025 with fourth quarter revenue of US$4.9 billion and basic EPS of US$0.36, alongside net income excluding extra items of US$105 million. This sets a clear marker after a volatile year for earnings. Over the past six quarters, revenue has moved in a relatively tight band between US$4.3 billion and just under US$5.0 billion. Quarterly basic EPS has swung from a loss of US$7.62 in Q3 2025 to positive readings in Q1, Q2 and Q4, giving you a mixed...

Masco (MAS) closed out FY 2025 with fourth quarter revenue of US$1.8 billion and basic EPS of US$0.81, alongside net income of US$165 million, setting the tone for how the full year’s performance lands with investors. Over the past four quarters, the company has seen revenue move from US$7.8 billion on a trailing basis in Q4 2024 to US$7.6 billion in Q4 2025, while trailing EPS shifted from US$3.77 to US$3.88. This provides a clear view of how the top and bottom lines have been tracking...

Lumen Technologies recently appointed former Cisco executive Jeff Sharritts as Executive Vice President and Chief Revenue Officer, while also reporting fourth-quarter 2025 sales of US$3,041 million and a net loss of US$2 million, alongside full-year 2025 sales of US$12.40 billion and a net loss of US$1.74 billion. This combination of a high-profile commercial leadership change and a move from prior profitability to continued losses highlights both execution challenges and efforts to reshape...

Jim Cramer recently highlighted Atlassian (NasdaqGS:TEAM) as a potentially undervalued software stock after a strong earnings beat and updated company guidance. The company reported results that outperformed expectations and management issued improved guidance, drawing positive attention from market commentators and analysts. At the same time, insider selling activity at Atlassian has picked up, which may prompt questions about how insiders view the current share price. The mix of public...

Enanta Pharmaceuticals Q1 2026 Earnings Snapshot Enanta Pharmaceuticals (ENTA) opened its 2026 financial year with Q1 revenue of US$18.6 million and a basic EPS loss of US$0.42, alongside a net income loss of US$11.9 million, setting a clear tone for where the business is today. The company has seen quarterly revenue fluctuate in a tight band between US$14.6 million and US$18.6 million over the last six reported periods, while basic EPS losses have ranged from about US$0.42 to US$1.36. This...

CTS (CTS) just closed out FY 2025 with fourth quarter revenue of US$137.3 million and basic EPS of US$0.68, capping a trailing twelve month run of US$541.3 million in revenue and EPS of US$2.21 that has supported 12.4% earnings growth over the past year. Over the last few quarters, revenue has moved from US$127.4 million in Q4 2024 to US$137.3 million in Q4 2025, while quarterly EPS has shifted from US$0.45 to US$0.68, against a backdrop of net margins stepping up from 11.3% to 12.1%...

In the first quarter ended January 2, 2026, MACOM Technology Solutions Holdings reported sales of US$271.61 million and net income of US$48.77 million, reversing a prior-year net loss and turning last year’s loss per share from continuing operations into earnings of US$0.64–US$0.65. Alongside this sharp swing back to profitability, MACOM issued revenue guidance of US$281 million to US$289 million for the April 3, 2026 quarter, signaling management confidence after a period of weaker...

Southwest Airlines (LUV) is back in focus after Directors C. David Cush and Gregg A. Saretsky submitted their resignations from the Board, and the company plans to shrink the Board to 11 members. See our latest analysis for Southwest Airlines. Those board changes come after a busy few weeks for Southwest Airlines, including its latest earnings release, 2026 guidance and a reaffirmed quarterly dividend, all against a strong run in the shares. The current share price of $54.07 sits on top of a...

Pharvaris recently announced that six abstracts featuring its lead candidate deucrictibant for hereditary angioedema, including first-time pivotal Phase 3 RAPIDe-3 data and final Phase 2 CHAPTER-1 results, were accepted for poster presentation at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting. This wave of data disclosures, spanning on-demand treatment, prophylaxis, and an extended-release tablet formulation, concentrates investor attention on Pharvaris’s effort to...